Clinical Trials
14 trialsNCT05420220 2026-05-28
Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 2 Completed
NCT04049474 2025-04-24
Bronchoscopic Cryo-Immunotherapy of Lung Cancer
NYU Langone Health
Phase EARLY_PHASE1 Completed
NCT02582125 2025-03-24
ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer
Ono Pharmaceutical Co., Ltd.
Phase 2 Completed
NCT04263051 2025-02-05
Optim-UCPVax
Centre Hospitalier Universitaire de Besancon
Phase 2 Completed
NCT02108964 2024-12-11
A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies
Novartis
Phase 1/2 Completed
NCT03681483 2024-07-10
RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT06329895 2024-07-05
A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy Participants
Bayer
Phase 1 Completed
NCT06378658 2024-07-05
A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants
Bayer
Phase 1 Completed
NCT06360211 2024-07-03
A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants
Bayer
Phase 1 Completed
NCT06221475 2024-06-28
A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants
Bayer
Phase 1 Completed
NCT03014648 2023-12-13
Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)
University of Pittsburgh
Phase 2 Completed
NCT00385606 2023-03-23
Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC
National Cancer Institute, Naples
Phase 2/3 Completed
NCT03693547 2023-01-10
Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）
Beijing Biostar Pharmaceuticals Co., Ltd.
Phase 2 Completed
NCT00487669 2014-01-09
Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)
Dartmouth-Hitchcock Medical Center
Phase 2 Completed